Key statistics
On Monday, Heron Therapeutics Inc (0J4V:LSE) closed at 1.22, 22.48% above the 52 week low of 1.00 set on Nov 04, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | 1.22 |
| Low | 1.22 |
| Bid | -- |
| Offer | -- |
| Previous close | 1.19 |
| Average volume | 36.63k |
|---|---|
| Shares outstanding | 188.54m |
| Free float | 181.69m |
| P/E (TTM) | -- |
| Market cap | 224.36m USD |
| EPS (TTM) | -0.1205 USD |
Data delayed at least 20 minutes, as of Mar 02 2026 18:56 GMT.
More ▼
Announcements
- Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results
- Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026
- Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth
- Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV)
- Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress
- Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors
- Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
More ▼
